Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

Let’s take a look at how Leslie's (NASDAQ:LESL) and the rest of the specialty retail stocks fared in Q2. PHOENIX, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Leslie's, Inc. ("Leslie's" or the “Company ...

Oil prices settle lower despite ongoing supply disruption concerns By Investing.com - Oct 11, 2024 1 Investing.com-- Oil prices settled lower Friday despite ongoing supply disruption concerns as ...

Unsellable Houses host Leslie Davis has marked Breast Cancer Awareness Month by opening up about a recent health scare and urging her followers to get themselves checked. Taking to her Instagram ...

After hours: October 22 at 5:17 PM EDT Loading Chart for LESL ...

Inject British luxury into your wardrobe with Ted Baker dresses. The brand's instantly recognisable floral prints adorn floaty silhouettes and elegant gowns – ideal for al fresco events. Look out for ...